In ₹ Crore except Per Share Latest Annual	INDSWFTLAB FY26	SMSPHARMA FY26	SOLARA FY26	DCAL FY26	Peer Average
Valuation — at last close
P/E	76.56×	42.64×	—	◆ 23.93×	33.29× +130%
P/B	2.38×	5.67×	2.32×	◆ 0.35×	2.78× -14%
EV/EBITDA	63.57×	27.86×	18.87×	◆ 7.25×	17.99× +253%
Market Cap	₹3,291 Cr	₹4,453 Cr	₹2,910 Cr	₹2,334 Cr	₹3,232 Cr +2%
Growth
Revenue CAGR 3Y	-19.01%	◆ 19.32%	-1.76%	6.71%	8.09% -335%
Revenue CAGR 5Y	—	◆ 9.51%	-3.27%	8.93%	5.06%
Net Income CAGR 3Y	-4.53%	—	—	—	—
Revenue YoY (latest Q)	◆ 57.53%	5.57%	33.11%	-4.29%	11.46% +402%
Net Income YoY (latest Q)	328.31%	2.04%	◆ 381.78%	-347.24%	12.19% +2593%
Profitability
EBITDA Margin	7.03%	◆ 19.31%	13.64%	19.29%	17.41% -60%
Net Income Margin	6.46%	◆ 11.50%	-0.54%	3.32%	4.76% +36%
Return on Common Equity	3.24%	◆ 14.32%	-0.63%	1.56%	5.08% -36%
Return on Capital Employed	1.10%	◆ 14.30%	6.39%	2.57%	7.75% -86%
Return on Assets	2.66%	◆ 8.11%	-0.32%	0.89%	2.89% -8%
Credit & Quality
Total Debt/Equity	◆ 0.01×	0.46×	0.53×	0.42×	0.47× -98%
Interest Coverage	◆ 10.31×	5.69×	0.92×	1.30×	2.64× +291%
Scale — latest FY
Revenue / Total Income	₹641 Cr	₹887 Cr	₹1,369 Cr	₹2,932 Cr	₹1,729 Cr -63%
Net Income	₹41.4 Cr	₹102 Cr	−₹7.4 Cr	₹97.5 Cr	₹64 Cr -35%
Total Assets	₹1,673 Cr	₹1,362 Cr	₹2,333 Cr	₹11,923 Cr	₹5,206 Cr -68%
EPS	₹4.95	₹11.15	₹-1.68	₹6.22	₹5.23 -5%
Book Value per Share	₹159.38	₹83.91	₹281.48	₹425.82	₹263.74 -40%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.